Education
About Us
Working with TipRanks
Follow Us
Impedimed Limited (AU:IPD)
:IPD
Total Valuation
Impedimed Limited has a market cap or net worth of AU$75.38M. The enterprise value is ―.
Market CapAU$75.38M
Enterprise Value―
Share Statistics
Impedimed Limited has 2,037,429,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,037,429,300
Owned by Insiders0.64%
Owned by Institutions<0.01%
Financial Efficiency
Impedimed Limited’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -66.89%.
Return on Equity (ROE)-1.13
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-66.89%
Return on Capital Employed (ROCE)-0.67
Revenue Per Employee153.30K
Profits Per Employee0.00
Employee Count83
Asset Turnover0.31
Inventory Turnover2.03
Valuation Ratios
The current PE Ratio of Impedimed Limited is ―. Impedimed Limited’s PEG ratio is -0.20.
PE Ratio―
PS Ratio5.55
PB Ratio3.45
Price to Fair Value3.45
Price to FCF-4.52
Price to Operating Cash Flow-4.51
PEG Ratio-0.20
Income Statement
In the last 12 months, Impedimed Limited had revenue of 12.72M and earned -23.24M in profits. Earnings per share was -0.01.
Revenue12.72M
Gross Profit10.97M
Operating Income-24.23M
Pretax Income-23.21M
Net Income-23.24M
EBITDA-17.55M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -18.29M and capital expenditures -1.43M, giving a free cash flow of -19.72M billion.
Operating Cash Flow-18.29M
Free Cash Flow-19.72M
Free Cash Flow per Share>-0.01
Dividends & Yields
Impedimed Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.92
52-Week Price Change-33.93%
50-Day Moving Average0.04
200-Day Moving Average0.04
Relative Strength Index (RSI)47.71
Average Volume (3m)1.31M
Important Dates
Impedimed Limited upcoming earnings date is Feb 20, 2026, TBA (Confirmed).
Last Earnings DateOct 30, 2025
Next Earnings DateFeb 20, 2026
Ex-Dividend Date―
Financial Position
Impedimed Limited as a current ratio of 4.86, with Debt / Equity ratio of 70.70%
Current Ratio4.86
Quick Ratio4.71
Debt to Market Cap0.20
Net Debt to EBITDA0.44
Interest Coverage Ratio-22.15
Taxes
In the past 12 months, Impedimed Limited has paid 26.00K in taxes.
Income Tax26.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Impedimed Limited EV to EBITDA ratio is -3.59, with an EV/FCF ratio of -4.03.
EV to Sales4.95
EV to EBITDA-3.59
EV to Free Cash Flow-4.03
EV to Operating Cash Flow-4.30
Balance Sheet
Impedimed Limited has AU$17.69M in cash and marketable securities with AU$1.05M in debt, giving a net cash position of AU$16.65M billion.
Cash & Marketable SecuritiesAU$17.69M
Total DebtAU$1.05M
Net CashAU$16.65M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 87.88%, with operating margin of -190.44%, and net profit margin of -182.62%.
Gross Margin87.88%
Operating Margin-190.44%
Pretax Margin-182.42%
Net Profit Margin-182.62%
EBITDA Margin-137.95%
EBIT Margin-173.82%
Analyst Forecast
The average price target for Impedimed Limited is AU$0.10, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.10
Price Target Upside162.26% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast23.31%
EPS Growth Forecast-17.35%